Integrating Neurobiology and Neuroimaging into Research on Addiction and PTSD

将神经生物学和神经影像学整合到成瘾和创伤后应激障碍的研究中

基本信息

  • 批准号:
    9313226
  • 负责人:
  • 金额:
    $ 15.59万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-07-01 至 2020-06-30
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): This K02 Independent Scientist Award will significantly expand my potential to make important contributions to the field of drug abuse by increasing my knowledge of the neurobiology of addictions and allowing me to obtain expertise in neuroimaging and image analysis methodology. Over the past 17 years, my program of research has focused on substance use disorders (SUD), stress, and co-occurring posttraumatic stress disorder (PTSD), with a particular focus on the development of theory-based, concurrent behavioral interventions for comorbid SUD/PTSD. As a licensed clinical psychologist, my training and background has afforded me skills in research design, structured clinical and diagnostic interviews, conduct of randomized controlled trials, psychotherapy development, and human laboratory paradigms. In the last 20 years, extraordinary methodologic advances have led to incredible growth in understanding the neurobiologic underpinnings of addictions and other psychiatric disorders. The Psychiatry and Neuroscience Departments at MUSC have a constellation of faculty who have been leaders in research in this area. There has also been exponential growth in neuroimaging expertise on the MUSC campus, providing an opportunity for me to learn from and collaborate with world-renowned experts. My ongoing NIDA-sponsored R01 is a randomized controlled trial (RCT) of integrated treatment for SUD and PTSD among Veterans (R01 DA030143). Through collaborations with the MUSC imaging group, a protocol to obtain functional magnetic resonance imaging (fMRI) before and after treatment was added to my R01 project to permit examination of neural mechanisms underlying SUD/PTSD comorbidity and identify potential targets for treatment. However, my lack of formal training in neurobiology, neuroimaging and image analysis methodology will limit my ability to realize the full potential of the data collected. Thus, the primary career development goals of this K02 application are: (1) To obtain training in the neurobiology of both SUD and PTSD in order to better understand the neurobiologic SUD/PTSD interface; (2) To gain a solid foundation in neuroimaging and image analysis methodology in order to apply these skills to the analysis of the fMRI data from my current R01, other neuroimaging data available at my institute, and future research efforts; and (3) To continue professional development in areas critical to academic success, such as, mentorship of junior scientists and multidisciplinary collaborations. These goals represent a logical and synergistic expansion of my current expertise. The training provided will enhance the value of currently funded projects as well as those that are under review. Although my existing skill set will allow me to accomplish the Specific Aims of my current R01, I need additional training to fully utilize the neuroimaging data and to ask novel and meaningful questions that are on the cutting edge of drug abuse research. The K02 award will allow me to benefit from formal coursework and workshops, directed readings, individual tutoring and consultation with leaders in the field, hands-on training in brai imaging data acquisition, MRI methodology (e.g., functional and structural MRI, BOLD signal activation), image analysis methodology, and supervised practical experience analyzing relevant datasets. In summary, the overarching goal of the proposed K02 is to further my multidisciplinary independent program of research aimed at the development of evidence-based interventions for SUD and co-occurring PTSD. This award will provide me with the protected time necessary to fully engage in the training activities outlined in the career development plan, enabling me to take full advantage of expertise on the MUSC campus to enhance my skill set and knowledge base in order to move my research program forward in ways not currently possible without additional training.
 描述(由申请人提供):这个 K02 独立科学家奖将通过增加我对成瘾神经生物学的了解并让我获得神经影像和图像分析方法方面的专业知识,显着扩大我在药物滥用领域做出重要贡献的潜力。在过去的 17 年里,我的研究项目主要集中在物质使用障碍 (SUD)、压力和同时发生的创伤后应激障碍 (PTSD),特别关注基于理论的同步行为干预措施的开发作为一名有执照的临床心理学家,我的培训和背景为我提供了研究设计、结构化临床和诊断访谈、随机对照试验的实施、心理治疗开发和人类实验室范例方面的技能。非凡的方法论进步使得人们对成瘾和其他精神疾病的神经生物学基础的理解取得了令人难以置信的进步,MUSC 的精神病学和神经科学系拥有一批在该领域研究中处于领先地位的教师。 MUSC 校园的神经影像学专业知识也呈指数级增长,为我提供了向世界知名专家学习和合作的机会。退伍军人中的 PTSD(R01 DA030143) 通过与 MUSC 成像小组合作,在我的 R01 项目中添加了治疗前后获得功能性磁共振成像 (fMRI) 的协议,以便进行检查。然而,我缺乏神经生物学、神经影像学和图像分析方法方面的正式培训,这将限制我充分发挥所收集数据潜力的能力。该 K02 应用程序的目标是:(1) 获得 SUD 和 PTSD 神经生物学方面的培训,以便更好地理解神经生物学 SUD/PTSD 接口;(2) 为神经影像学和图像分析方法学奠定坚实的基础;为了将这些技能应用于对我当前 R01 的功能磁共振成像数据、我所在研究所提供的其他神经影像数据以及未来的研究工作的分析,以及 (3) 继续在对学术成功至关重要的领域进行专业发展,例如指导这些目标代表了我当前专业知识的逻辑和协同扩展,将提高当前资助的项目以及正在审查的项目的价值,尽管我现有的技能将使我能够完成这些任务。我当前的具体目标R01,我需要额外的培训来充分利用神经影像数据,并提出药物滥用研究前沿的新颖且有意义的问题,K02 奖将使我受益于正式课程和研讨会、定向阅读、个人辅导和。与该领域的领导者进行咨询、脑成像数据采集、MRI 方法(例如功能和结构 MRI、BOLD 信号激活)、图像分析方法以及分析相关数据集的监督实践经验的实践培训。拟议的 K02 的总体目标是我的多学科独立研究计划,旨在为 SUD 和同时发生的 PTSD 开发基于证据的干预措施。该奖项将为我提供进一步充分参与概述的培训活动所需的受保护时间。在职业发展计划中,使我能够充分利用 MUSC 校园的专业知识来增强我的技能和知识基础,以便以目前在没有额外培训的情况下不可能实现的方式推进我的研究项目。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SUDIE E BACK其他文献

SUDIE E BACK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SUDIE E BACK', 18)}}的其他基金

Integration of Cognitive Processing Therapy and Relapse Prevention for Alcohol Use Disorder and Co-Occurring PTSD: A Randomized Clinical Trial
认知处理疗法与酒精使用障碍和并发 PTSD 复发预防的整合:一项随机临床试验
  • 批准号:
    10934633
  • 财政年份:
    2023
  • 资助金额:
    $ 15.59万
  • 项目类别:
Oxytocin to Enhance Integrated Exposure-Based Treatment of Co-occurring Alcohol Use Disorder and PTSD
催产素可增强对同时发生的酒精使用障碍和创伤后应激障碍的综合暴露治疗
  • 批准号:
    10097893
  • 财政年份:
    2020
  • 资助金额:
    $ 15.59万
  • 项目类别:
Oxytocin to Enhance Integrated Exposure-Based Treatment of Co-occurring Alcohol Use Disorder and PTSD
催产素可增强对同时发生的酒精使用障碍和创伤后应激障碍的综合暴露治疗
  • 批准号:
    10262945
  • 财政年份:
    2020
  • 资助金额:
    $ 15.59万
  • 项目类别:
Oxytocin to Enhance Integrated Exposure-Based Treatment of Co-occurring Alcohol Use Disorder and PTSD
催产素可增强对同时发生的酒精使用障碍和创伤后应激障碍的综合暴露治疗
  • 批准号:
    10478268
  • 财政年份:
    2020
  • 资助金额:
    $ 15.59万
  • 项目类别:
Intelligent Biometrics to Optimize Prolonged Exposure Treatment for PTSD (IB-PE)
智能生物识别技术优化 PTSD 长期暴露治疗 (IB-PE)
  • 批准号:
    10018114
  • 财政年份:
    2019
  • 资助金额:
    $ 15.59万
  • 项目类别:
Intelligent Biometrics to Optimize Prolonged Exposure Treatment for PTSD (IB-PE)
智能生物识别技术优化 PTSD 长期暴露治疗 (IB-PE)
  • 批准号:
    9907260
  • 财政年份:
    2019
  • 资助金额:
    $ 15.59万
  • 项目类别:
Intelligent Biometrics to Optimize Prolonged Exposure Treatment for PTSD (IB-PE)
智能生物识别技术优化 PTSD 长期暴露治疗 (IB-PE)
  • 批准号:
    10083277
  • 财政年份:
    2019
  • 资助金额:
    $ 15.59万
  • 项目类别:
Randomized Controlled Trial of N-acetylcysteine for Alcohol Use Disorder and Comorbid PTSD
N-乙酰半胱氨酸治疗酒精使用障碍和共病 PTSD 的随机对照试验
  • 批准号:
    10209312
  • 财政年份:
    2016
  • 资助金额:
    $ 15.59万
  • 项目类别:
A Randomized Controlled Trial of N-Acetylcysteine for Alcohol Use Disorder and Comorbid PTSD
N-乙酰半胱氨酸治疗酒精使用障碍和共病 PTSD 的随机对照试验
  • 批准号:
    9982151
  • 财政年份:
    2016
  • 资助金额:
    $ 15.59万
  • 项目类别:
A Randomized Controlled Trial of N-Acetylcysteine for Alcohol Use Disorder and Comorbid PTSD
N-乙酰半胱氨酸治疗酒精使用障碍和共病 PTSD 的随机对照试验
  • 批准号:
    9329345
  • 财政年份:
    2016
  • 资助金额:
    $ 15.59万
  • 项目类别:

相似国自然基金

TiC-TiB2颗粒喷射成形原位合成及其对M2高速工具钢共晶碳化物形成与演化的影响
  • 批准号:
    52361020
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
植被群落演替对河道水流结构和纵向离散特性影响机制研究
  • 批准号:
    52309088
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
热带印度洋海表皮温日变化的数值模拟及对海气热通量的影响
  • 批准号:
    42376002
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
  • 批准号:
    82300697
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
协同遥感和气候模型的城市高温热浪时空特征及其对热暴露影响研究
  • 批准号:
    42371397
  • 批准年份:
    2023
  • 资助金额:
    46 万元
  • 项目类别:
    面上项目

相似海外基金

Neuromodulation for impulsivity and suicidality in Veterans with mildtraumatic brain injury and common co-occurring mental health conditions
神经调节对患有轻度脑损伤和常见并发心理健康状况的退伍军人的冲动和自杀倾向
  • 批准号:
    10640567
  • 财政年份:
    2023
  • 资助金额:
    $ 15.59万
  • 项目类别:
Using in-vivo Real-time Biosensor to Evaluate Prodrugs Designed to Prolong Therapeutic Effects for Smoking Cessation.
使用体内实时生物传感器评估旨在延长戒烟治疗效果的前药。
  • 批准号:
    10546293
  • 财政年份:
    2023
  • 资助金额:
    $ 15.59万
  • 项目类别:
A Mobile App to Address Co-Occurring Sleep Problems and Heavy Alcohol Use among Veterans Outside of Care Settings
一款解决退伍军人在护理机构之外同时发生的睡眠问题和酗酒问题的移动应用程序
  • 批准号:
    10647530
  • 财政年份:
    2023
  • 资助金额:
    $ 15.59万
  • 项目类别:
Immunogenomic predictors of outcomes in patients with locally advanced cervical cancer treated with immunotherapy and chemoradiation
接受免疫治疗和放化疗的局部晚期宫颈癌患者结果的免疫基因组预测因子
  • 批准号:
    10908093
  • 财政年份:
    2023
  • 资助金额:
    $ 15.59万
  • 项目类别:
Psilocybin and Affective Function in Chronic Lower Back Pain and Depression
裸盖菇素与慢性腰痛和抑郁症的情感功能
  • 批准号:
    10626449
  • 财政年份:
    2023
  • 资助金额:
    $ 15.59万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了